InnoMedica Schweiz AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Subsidiary
- Established
- 1988-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ipag.ch
Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- InnoMedica Schweiz AG
- Target Recruit Count
- 40
- Registration Number
- NCT06431971
- Locations
- 🇨🇭
Neurologisches Institut Konolfingen, Konolfingen, Switzerland
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- InnoMedica Schweiz AG
- Target Recruit Count
- 22
- Registration Number
- NCT04976127
- Locations
- 🇨🇭
Neurologisches Institut Konolfingen, Konolfingen, Bern, Switzerland
News
No news found